Hospital Reimbursement Price Cap for Cancer Drugs: the French experience in controlling hospital drug expenditures
Year of publication: |
2012
|
---|---|
Authors: | Degrassat-Théas, Albane ; Bensadon, M. ; Rieu, C. ; Angalakuditi, M. ; Le Pen, Claude ; Paubel, Pascal |
Institutions: | Université Paris-Dauphine (Paris IX) |
Subject: | Health administration | Quality of life research | Health economics |
Series: | |
---|---|
Type of publication: | Book / Working Paper |
Notes: | Published in Pharmacoeconomics, 2012, Vol. 30, no. 7. pp. 565-573.Length: 8 pages |
Classification: | I18 - Government Policy; Regulation; Public Health ; L65 - Chemicals; Rubber; Drugs; Biotechnology ; I11 - Analysis of Health Care Markets ; H51 - Government Expenditures and Health |
Source: |
-
Degrassat-Théas, Albane, (2013)
-
Vadia, Rucha, (2020)
-
How Far is Germany From Value-Based Pricing 10 Years After the Introduction of AMNOG?
Dintsios, Charalabos-Markos, (2021)
- More ...
-
Public regulation of the cancer drugs market in French hospitals
Le Pen, Claude, (2009)
-
Degrassat-Théas, Albane, (2013)
-
Sinègre, Martine, (2011)
- More ...